McKesson | MCK - Selling And Administration Expenses

Stock Price
847.79
Daily Change
1.28 0.15%
Monthly
2.77%
Yearly
40.52%
Q1 Forecast
805.61

McKesson reported $2.07B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Acadia Healthcare USD 2.28B 1.77B Sep/2025
Align Technology USD 417.8M 30.89M Sep/2025
Cardinal Health USD 1.46B 23M Sep/2025
Centene USD 3.13B 98M Sep/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Cigna USD 3.19B 242M Sep/2025
DaVita Healthcare Partners USD 414.37M 1.57M Sep/2025
Dentsply International USD 355M 21M Sep/2025
Elevance Health USD 10.91B 309M Dec/2025
Encompass Health USD 56.1M 3.3M Sep/2025
HCA USD 38.4B 978M Sep/2025
Henry Schein USD 760M 17M Sep/2025
Humana USD 3.36B 614M Mar/2025
IQVIA Holdings USD 514M 5M Sep/2025
J&J USD 6.75B 831M Dec/2025
Laboratory Of America USD 552.4M 26.9M Sep/2025
McKesson USD 2.07B 122M Sep/2025
Molina Healthcare USD 1.24B 94M Sep/2025
Owens Minor USD 462.35M 30.72M Mar/2025
Quest Diagnostics USD 501M 15M Sep/2025
Stryker USD 2.14B 150M Dec/2025
Tenet Healthcare USD 102M 2.06B Sep/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Universal Health Services USD 414.58M 4.2M Sep/2025